Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes

Paediatric Mycoplasma pneumoniae pneumonia (MPP) is a heterogeneous disease with a diverse spectrum of clinical phenotypes. No studies have demonstrated the relationship between underlying endotypes and clinical phenotypes as well as prognosis about this disease. Thus, we conducted a multicentre pro...

Full description

Bibliographic Details
Main Authors: Heng Wang, Yanli Zhang, Chengsong Zhao, Yun Peng, Wenqi Song, Weihan Xu, Xiaohui Wen, Jinrong Liu, Haiming Yang, Ruihe Shi, Shunying Zhao
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2024.2324078
_version_ 1826947204088070144
author Heng Wang
Yanli Zhang
Chengsong Zhao
Yun Peng
Wenqi Song
Weihan Xu
Xiaohui Wen
Jinrong Liu
Haiming Yang
Ruihe Shi
Shunying Zhao
author_facet Heng Wang
Yanli Zhang
Chengsong Zhao
Yun Peng
Wenqi Song
Weihan Xu
Xiaohui Wen
Jinrong Liu
Haiming Yang
Ruihe Shi
Shunying Zhao
author_sort Heng Wang
collection DOAJ
description Paediatric Mycoplasma pneumoniae pneumonia (MPP) is a heterogeneous disease with a diverse spectrum of clinical phenotypes. No studies have demonstrated the relationship between underlying endotypes and clinical phenotypes as well as prognosis about this disease. Thus, we conducted a multicentre prospective longitudinal study on children hospitalized for MPP between June 2021 and March 2023, with the end of follow-up in August 2023. Blood samples were collected and processed at multiple time points. Multiplex cytokine assay was performed to characterize serum cytokine profiles and their dynamic changes after admission. Cluster analysis based on different clinical phenotypes was conducted. Among the included 196 patients, the levels of serum IL-17A and IL-6 showed remarkable variabilities. Four cytokine clusters based on the two cytokines and four clinical groups were identified. Significant elevation of IL-17A mainly correlated with diffuse bronchiolitis and lobar lesion by airway mucus hypersecretions, while that of IL-6 was largely associated with lobar lesion which later developed into lung necrosis. Besides, glucocorticoid therapy failed to inhibit IL-17A, and markedly elevated IL-17A and IL-6 levels may correlate with lower airway obliterans. Our study provides critical relationship between molecular signatures (endotypes) and clustered clinical phenotypes in paediatric patients with MPP.
first_indexed 2024-04-24T13:36:45Z
format Article
id doaj.art-bd2cca0d12154506af8b877efdac2b2c
institution Directory Open Access Journal
issn 2222-1751
language English
last_indexed 2025-02-17T21:27:03Z
publishDate 2024-12-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj.art-bd2cca0d12154506af8b877efdac2b2c2024-12-07T04:40:17ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512024-12-0113110.1080/22221751.2024.2324078Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypesHeng Wang0Yanli Zhang1Chengsong Zhao2Yun Peng3Wenqi Song4Weihan Xu5Xiaohui Wen6Jinrong Liu7Haiming Yang8Ruihe Shi9Shunying Zhao10Department II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDivision of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Henan, People’s Republic of ChinaDepartment of Infectious Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment of Radiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment of Clinical Laboratory, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDepartment II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaDivision of Pulmonology, Department of Pediatrics, Third Affiliated Hospital of Zhengzhou University, Henan, People’s Republic of ChinaDepartment II of Respiratory Medicine, National Clinical Research Center for Respiratory Diseases, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, People’s Republic of ChinaPaediatric Mycoplasma pneumoniae pneumonia (MPP) is a heterogeneous disease with a diverse spectrum of clinical phenotypes. No studies have demonstrated the relationship between underlying endotypes and clinical phenotypes as well as prognosis about this disease. Thus, we conducted a multicentre prospective longitudinal study on children hospitalized for MPP between June 2021 and March 2023, with the end of follow-up in August 2023. Blood samples were collected and processed at multiple time points. Multiplex cytokine assay was performed to characterize serum cytokine profiles and their dynamic changes after admission. Cluster analysis based on different clinical phenotypes was conducted. Among the included 196 patients, the levels of serum IL-17A and IL-6 showed remarkable variabilities. Four cytokine clusters based on the two cytokines and four clinical groups were identified. Significant elevation of IL-17A mainly correlated with diffuse bronchiolitis and lobar lesion by airway mucus hypersecretions, while that of IL-6 was largely associated with lobar lesion which later developed into lung necrosis. Besides, glucocorticoid therapy failed to inhibit IL-17A, and markedly elevated IL-17A and IL-6 levels may correlate with lower airway obliterans. Our study provides critical relationship between molecular signatures (endotypes) and clustered clinical phenotypes in paediatric patients with MPP.https://www.tandfonline.com/doi/10.1080/22221751.2024.2324078Paediatric Mycoplasma pneumoniae pneumoniacytokine profileendotypephenotypelower airway obliterans
spellingShingle Heng Wang
Yanli Zhang
Chengsong Zhao
Yun Peng
Wenqi Song
Weihan Xu
Xiaohui Wen
Jinrong Liu
Haiming Yang
Ruihe Shi
Shunying Zhao
Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
Emerging Microbes and Infections
Paediatric Mycoplasma pneumoniae pneumonia
cytokine profile
endotype
phenotype
lower airway obliterans
title Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
title_full Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
title_fullStr Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
title_full_unstemmed Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
title_short Serum IL-17A and IL-6 in paediatric Mycoplasma pneumoniae pneumonia: implications for different endotypes
title_sort serum il 17a and il 6 in paediatric mycoplasma pneumoniae pneumonia implications for different endotypes
topic Paediatric Mycoplasma pneumoniae pneumonia
cytokine profile
endotype
phenotype
lower airway obliterans
url https://www.tandfonline.com/doi/10.1080/22221751.2024.2324078
work_keys_str_mv AT hengwang serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT yanlizhang serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT chengsongzhao serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT yunpeng serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT wenqisong serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT weihanxu serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT xiaohuiwen serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT jinrongliu serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT haimingyang serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT ruiheshi serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes
AT shunyingzhao serumil17aandil6inpaediatricmycoplasmapneumoniaepneumoniaimplicationsfordifferentendotypes